CD14 and familial pancreatic carcinoma: A lower frequency of peripheral blood CD14+CD16– monocytes was associated with their increase in bone marrow and greater survival in pancreatic cancer,76 suggesting that pancreatic tumors systemically alter monocyte trafficking.